Activate your knowledge advantage with access to millions of scholarly publications, peer-reviewed research articles, evidence-based clinical decision resources and authoritative data sources curated by EBSCO, your leading global provider of comprehensive and authoritative research databases and evidence-based clinical decision resources for universities, colleges, hospitals, corporations, governments, K-12 schools and public libraries.
Everything you need to know from emerging and advanced research to archives and trusted sources
Consumer Health
Blood cancers, including leukemia, lymphoma, and myeloma, make up nearly 10% of all new cancer diagnoses in the U.S., with the American Cancer Society reporting an estimated 184,720 new cases and 57,670 deaths in 2024, underscoring the urgent need for early detection, improved therapies, and sustained research investment.
Health and Medicine
According to the Centers for Disease Control and Prevention and the American Cancer Society, ovarian cancer is the second most common gynecologic cancer in the U.S., with over 60% of cases diagnosed at stage III or IV and about 20,900 new cases and 12,700 deaths projected in 2025, highlighting the importance of awareness of early symptoms and hereditary risk factors such as BRCA mutations.
Health and Medicine
Prostate cancer is the second most common cancer among American men and the second-leading cause of cancer-related death, with 2025 projections from the American Cancer Society estimating 313,780 new cases and 35,770 deaths; the disease most often affects men over 65, underscoring the value of early detection through PSA screening and DRE when survival prospects are strongest.
Access world-class research databases trusted by the world's top thinkers, thought leaders and influencers spanning all subject areas of discipline. Curated by EBSCO to enable and advance research that transforms lives, unlocking the impossible and accelerating the pace of innovation. Access EBSCOhost via your institution.
Built for serious scholarship, this resource spans 10,000+ active full-text journals, 7,000+ active open access titles, cited references, and archival video, delivering authoritative content across nearly every discipline.
Access is provided exclusively via participating institutions.
Designed for future leaders and professionals, the collection delivers access to 3,600+ active full-text journals, 2,000+ active open access titles, and thousands of business videos, equipping students and professionals with trusted, global perspectives.
Access is provided exclusively via participating institutions.
With more than 2,500 active full-text journals and extensive international coverage, this flagship database delivers the trusted scientific and biomedical research that medical professionals and pharma leaders rely on to inform discovery, innovation, and improve patient outcomes.
Access is provided exclusively via participating institutions.
From breaking discoveries to deep dives, EBSCO has all the information resources to help you push boundaries, drive breakthroughs and make decisions faster.
Changes in woodland cover are expected to have major impacts on social-ecological systems.
Cutting-edge research on privacy protection technologies in biometric systems using advanced machine learning techniques.
Research examines cost behavior impact of industry characteristics on managerial decision making.
For decades, organizations and researchers have relied on our vetted information to guide critical decisions and research. Authority is not a claim, it is our legacy, trusted across industries and time. Whatever the need, one standard remains: information you can trust, sources you can depend on.
Learn how the Daniel Cosío Villegas Library at the Colegio de México sparked sustainability awareness for libraries across Mexico, with the help of the EBSCO Solar grant.
How Africa Studies Source showcases regional scholarship and serves researchers focused on Africa.
From target selection to regulatory submissions, peer-reviewed literature strengthens every stage of the pipeline. It provides the external validation, benchmarks, and clinical precedent R&D leaders need to reduce risk, accelerate timelines, and make confident decisions.
